A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01217632
Recruitment Status : Terminated (Study terminated due to an unexpected prominent effect of entecavir alone in this patient population.)
First Posted : October 8, 2010
Last Update Posted : August 16, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2015
  Study Completion Date : June 2015